In the present study, we carefully analyzed MDM2 and MDM4 expression levels in various cancer cell lines with and without TP53 mutations and found that MDM2 and MDM4 were deregulated in all wt TP53 cancer cells. This evidence concerns the gene MDM4 and cancer.